Spelling suggestions: "subject:"glycolic acid"" "subject:"glycolic cid""
1 |
The metabolism of glycolic acid in tobacco leavesMann, Jay D. January 1957 (has links)
Thesis (Ph. D.)--University of Wisconsin--Madison, 1957. / Typescript. Abstracted in Dissertation abstracts, v. 17 (1957) no. 11, p. 2408. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references (leaves 78-84).
|
2 |
Extracellular glycolic acid accumulation in natural water and laboratory culturesSpear, Richard Duane, January 1966 (has links)
Thesis (M.S.)--University of Wisconsin--Madison, 1966. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
3 |
Polymer Nanoparticle Characterization and Applications for Drug DeliveryRoberts, Rose A. 30 January 2019 (has links)
Nanoparticle usage continues to increase in everyday products, from cosmetics to food preservation coatings, drug delivery to polymer fillers. Their characterization and synthesis is of utmost importance to ensure safety and improved product quality. Nanoparticles can be sourced naturally or synthetically fabricated. Cellulose nanocrystals (CNCs) are rod-like nanoparticles that can be isolated from nature. Reliable methods of characterization are necessary to ensure quality control. However, their physical characteristics cause challenges for imaging under transmission electron microscopy (TEM) with a high enough resolution for dimensional analysis. Heavy metal staining such as radioactive uranyl acetate is often used to increase contrast and TEM sample substrate preparation techniques often use expensive equipment such as glow discharge in order to prevent CNC agglomeration. A method to reliably produce TEM images of CNCs without using radioactive stains or expensive glow discharge equipment was developed, using a vanadium-based stain branded NanoVan® and bovine serum albumin to keep CNCs dispersed while drying on the TEM substrate. Due to their aspect ratio, there is also concern of toxicity to the lungs. The concentration of CNCs in air in production facilities must be monitored, but there is currently no method tailored to CNCs. A method using UV-vis spectroscopy, dynamic light scattering, TEM, and scanning mobility particle sizer in conjunction with impinger collectors was developed for monitoring aerosolized CNC concentration. Synthetic nanoparticles are often used for controlled drug delivery systems. A new peptide drug termed αCT1 has been shown to interact with cell communication in a way that promotes wound healing, reduces inflammation and scarring, and aids in cancer therapy. However, the peptide's half-life in the body is estimated to be less than a day, which is not conducive to long-term treatments. Controlling its release into the body over several weeks can decrease the number of doses required, which is especially useful for glioblastoma treatment. Poly(lactic-co-glycolic acid) (PLGA) is often used for drug encapsulation since it hydrolyzes in the body and is biocompatible. Two methods of αCT1 encapsulation in PLGA were explored. It was found that flash nanoprecipitation increased loading of αCT1 in the particles by 1-2 orders of magnitude compared with the double emulsion method. Particles released αCT1 over three weeks and were non-cytotoxic. / PHD / Nanoparticle usage continues to increase in everyday products, from cosmetics to food preservation coatings, drug delivery to polymer fillers. Understanding the nature of nanoparticles is important to ensure safety and quality of commercial products, and production of particles allows for tailoring for specific applications. In this work, a technique to more easily create samples of cellulose nanocrystals (CNCs) for electron microscopy is developed. Electron microscopy can then be used to measure the size of these rod-like particles. Then, the technique is used to help develop a method to measure the concentration of CNCs in air. CNCs may irritate the lungs, so development of a way to measure their concentration in air is important to ensure safety of plant workers and consumers of CNCs. Characterization techniques of CNCs were used for synthesized particles used for brain cancer treatment. Synthesized particles contain the drug αCT1, which has been shown to reduce glioblastoma, or brain cancer, from becoming resistant to chemotherapy. These particles were made using poly(lactic-co-glycolic acid) (PLGA), a polymer that degrades in the body into lactic acid and glycolic acid. PLGA particles released αCT1 over three weeks and are of a size that is compatible with the brain. However, loading of the drug was low when using the first synthesis method. By switching particle synthesis methods, drug loading in the particles was increased by 1-2 orders of magnitude.
|
4 |
Estudo experimetal comparativo da histotoxicidade entre o copolímero de poli (ácido láctico-co-glicólico) e a blenda poli (ácido láctico-co-glicólico) / poli (isopreno)Kim, Jung Ho January 2012 (has links)
Introdução: A aplicação clínica de biomateriais está se expandindo para diversas especialidades médicas. Dentre os diversos tipos de biomateriais, os classificados como temporários merecem atenção especial, pois são assimilados pelo organismo após exercerem sua função, evitando, assim, procedimento cirúrgico para sua retirada. O copolímero de poli (ácido láctico-co-glicólico) (PLGA) é um tipo de biomaterial temporário, rotineiramente utilizado na medicina na forma de fios de sutura e implantes ortopédicos. A mistura do PLGA com o poli (isopreno) resulta em uma blenda (PLGA / PI), de alta resistência e tenacidade, que foi desenvolvida pelo Laboratório de Biomateriais do Instituto de Engenharia da UFRGS. Entretanto, não existem estudos “in vivo” testando a reação óssea desta blenda. Objetivo: Testar a histotoxicidade da blenda de PLGA / PI em relação ao biopolímero já consagrado PLGA. Método: Foram utilizados 46 ratos machos wistar (Rattusnorvegicus - linhagem albina), divididos em 2 grupos conforme o material implantado (PLGA ou PLGA / PI) na calota craniana, e subdivididos em tempos de morte (15, 30, 60 e 90 dias). Os procedimentos foram realizados na Unidade de Experimentação Animal (UEA) do Hospital de Clínicas de Porto Alegre (HCPA). Após a morte, a calota craniana foi retirada, submetida ao exame histopatológico e aplicado o escore de Dadas e cols (14) modificado. Resultados: A diferença da histotoxicidade dos dois materiais não foi significativa nos períodos 15, 30 e 90 dias, porém foi significativa no período 60 dias. Conclusão: A histotoxicidade do PLGA / PI, ao final do estudo (90 dias), foi semelhante ao PLGA, demonstrando equivalência em longo prazo. O período de 60 dias pós-cirúrgico (grupo da blenda) foi o único em que a histotoxicidade mostrou-se significativamente maior. Mais estudos devem ser feitos para melhorar o entendimento desta variação. / Introduction: Clinical application of biomaterials is expanding to various medical specialties. Among the different types of biomaterials, those classified as temporary deserve special attention because they are assimilated by the body after exercising their function, thereby avoiding surgical procedure for their removal. Co-polymer poly (lactic-co-glycolic acid) (PLGA) is a type of temporary biomaterial, routinely used in medicine as suture threads and orthopedic implants. The mixture of PLGA with poly (isoprene) results in a high-strength and thoughness blend (PLGA / PI), developed by the Biomaterials Laboratory of the Engineering Institute/ UFRGS. However, there are no studies “in vivo” testing the bone reaction of that blend. Objective: To Test histotoxicity of PLGA / PI blend over the already established biopolymer, PLGA. Method: Forty six male Wistar rats (Rattus norvegicus – albino strain), divided into 2 groups according to the material (PLGA or PLGA / PI) implanted in the skull and sub divided into periods of death (15, 30, 60 and 90 days). The procedures were developed in the Animal Experiment Unit (AEU) of Hospital de Clínicas de Porto Alegre (HCPA). After death, the skull was removed, submitted to histopathologic examination and the modified Dadas’ et all score was used (14). Results: The histotoxicity difference of the two materials was not significant in the periods of 15, 30 and 90 days, but it was significant in the period of 60 days. Conclusion: At the end of the study (90 days), the PLGA / PI histotoxicity was similar to PLGA, showing longterm equivalence. The 60-day post-surgical period was the only one in which histotoxicity was significantly higher (blend group). More studies shall be done in in order to better understand that variation.
|
5 |
Estudo experimetal comparativo da histotoxicidade entre o copolímero de poli (ácido láctico-co-glicólico) e a blenda poli (ácido láctico-co-glicólico) / poli (isopreno)Kim, Jung Ho January 2012 (has links)
Introdução: A aplicação clínica de biomateriais está se expandindo para diversas especialidades médicas. Dentre os diversos tipos de biomateriais, os classificados como temporários merecem atenção especial, pois são assimilados pelo organismo após exercerem sua função, evitando, assim, procedimento cirúrgico para sua retirada. O copolímero de poli (ácido láctico-co-glicólico) (PLGA) é um tipo de biomaterial temporário, rotineiramente utilizado na medicina na forma de fios de sutura e implantes ortopédicos. A mistura do PLGA com o poli (isopreno) resulta em uma blenda (PLGA / PI), de alta resistência e tenacidade, que foi desenvolvida pelo Laboratório de Biomateriais do Instituto de Engenharia da UFRGS. Entretanto, não existem estudos “in vivo” testando a reação óssea desta blenda. Objetivo: Testar a histotoxicidade da blenda de PLGA / PI em relação ao biopolímero já consagrado PLGA. Método: Foram utilizados 46 ratos machos wistar (Rattusnorvegicus - linhagem albina), divididos em 2 grupos conforme o material implantado (PLGA ou PLGA / PI) na calota craniana, e subdivididos em tempos de morte (15, 30, 60 e 90 dias). Os procedimentos foram realizados na Unidade de Experimentação Animal (UEA) do Hospital de Clínicas de Porto Alegre (HCPA). Após a morte, a calota craniana foi retirada, submetida ao exame histopatológico e aplicado o escore de Dadas e cols (14) modificado. Resultados: A diferença da histotoxicidade dos dois materiais não foi significativa nos períodos 15, 30 e 90 dias, porém foi significativa no período 60 dias. Conclusão: A histotoxicidade do PLGA / PI, ao final do estudo (90 dias), foi semelhante ao PLGA, demonstrando equivalência em longo prazo. O período de 60 dias pós-cirúrgico (grupo da blenda) foi o único em que a histotoxicidade mostrou-se significativamente maior. Mais estudos devem ser feitos para melhorar o entendimento desta variação. / Introduction: Clinical application of biomaterials is expanding to various medical specialties. Among the different types of biomaterials, those classified as temporary deserve special attention because they are assimilated by the body after exercising their function, thereby avoiding surgical procedure for their removal. Co-polymer poly (lactic-co-glycolic acid) (PLGA) is a type of temporary biomaterial, routinely used in medicine as suture threads and orthopedic implants. The mixture of PLGA with poly (isoprene) results in a high-strength and thoughness blend (PLGA / PI), developed by the Biomaterials Laboratory of the Engineering Institute/ UFRGS. However, there are no studies “in vivo” testing the bone reaction of that blend. Objective: To Test histotoxicity of PLGA / PI blend over the already established biopolymer, PLGA. Method: Forty six male Wistar rats (Rattus norvegicus – albino strain), divided into 2 groups according to the material (PLGA or PLGA / PI) implanted in the skull and sub divided into periods of death (15, 30, 60 and 90 days). The procedures were developed in the Animal Experiment Unit (AEU) of Hospital de Clínicas de Porto Alegre (HCPA). After death, the skull was removed, submitted to histopathologic examination and the modified Dadas’ et all score was used (14). Results: The histotoxicity difference of the two materials was not significant in the periods of 15, 30 and 90 days, but it was significant in the period of 60 days. Conclusion: At the end of the study (90 days), the PLGA / PI histotoxicity was similar to PLGA, showing longterm equivalence. The 60-day post-surgical period was the only one in which histotoxicity was significantly higher (blend group). More studies shall be done in in order to better understand that variation.
|
6 |
Estudo experimetal comparativo da histotoxicidade entre o copolímero de poli (ácido láctico-co-glicólico) e a blenda poli (ácido láctico-co-glicólico) / poli (isopreno)Kim, Jung Ho January 2012 (has links)
Introdução: A aplicação clínica de biomateriais está se expandindo para diversas especialidades médicas. Dentre os diversos tipos de biomateriais, os classificados como temporários merecem atenção especial, pois são assimilados pelo organismo após exercerem sua função, evitando, assim, procedimento cirúrgico para sua retirada. O copolímero de poli (ácido láctico-co-glicólico) (PLGA) é um tipo de biomaterial temporário, rotineiramente utilizado na medicina na forma de fios de sutura e implantes ortopédicos. A mistura do PLGA com o poli (isopreno) resulta em uma blenda (PLGA / PI), de alta resistência e tenacidade, que foi desenvolvida pelo Laboratório de Biomateriais do Instituto de Engenharia da UFRGS. Entretanto, não existem estudos “in vivo” testando a reação óssea desta blenda. Objetivo: Testar a histotoxicidade da blenda de PLGA / PI em relação ao biopolímero já consagrado PLGA. Método: Foram utilizados 46 ratos machos wistar (Rattusnorvegicus - linhagem albina), divididos em 2 grupos conforme o material implantado (PLGA ou PLGA / PI) na calota craniana, e subdivididos em tempos de morte (15, 30, 60 e 90 dias). Os procedimentos foram realizados na Unidade de Experimentação Animal (UEA) do Hospital de Clínicas de Porto Alegre (HCPA). Após a morte, a calota craniana foi retirada, submetida ao exame histopatológico e aplicado o escore de Dadas e cols (14) modificado. Resultados: A diferença da histotoxicidade dos dois materiais não foi significativa nos períodos 15, 30 e 90 dias, porém foi significativa no período 60 dias. Conclusão: A histotoxicidade do PLGA / PI, ao final do estudo (90 dias), foi semelhante ao PLGA, demonstrando equivalência em longo prazo. O período de 60 dias pós-cirúrgico (grupo da blenda) foi o único em que a histotoxicidade mostrou-se significativamente maior. Mais estudos devem ser feitos para melhorar o entendimento desta variação. / Introduction: Clinical application of biomaterials is expanding to various medical specialties. Among the different types of biomaterials, those classified as temporary deserve special attention because they are assimilated by the body after exercising their function, thereby avoiding surgical procedure for their removal. Co-polymer poly (lactic-co-glycolic acid) (PLGA) is a type of temporary biomaterial, routinely used in medicine as suture threads and orthopedic implants. The mixture of PLGA with poly (isoprene) results in a high-strength and thoughness blend (PLGA / PI), developed by the Biomaterials Laboratory of the Engineering Institute/ UFRGS. However, there are no studies “in vivo” testing the bone reaction of that blend. Objective: To Test histotoxicity of PLGA / PI blend over the already established biopolymer, PLGA. Method: Forty six male Wistar rats (Rattus norvegicus – albino strain), divided into 2 groups according to the material (PLGA or PLGA / PI) implanted in the skull and sub divided into periods of death (15, 30, 60 and 90 days). The procedures were developed in the Animal Experiment Unit (AEU) of Hospital de Clínicas de Porto Alegre (HCPA). After death, the skull was removed, submitted to histopathologic examination and the modified Dadas’ et all score was used (14). Results: The histotoxicity difference of the two materials was not significant in the periods of 15, 30 and 90 days, but it was significant in the period of 60 days. Conclusion: At the end of the study (90 days), the PLGA / PI histotoxicity was similar to PLGA, showing longterm equivalence. The 60-day post-surgical period was the only one in which histotoxicity was significantly higher (blend group). More studies shall be done in in order to better understand that variation.
|
7 |
Controlled Release System for Localized and Sustained Drug Delivery ApplicationsRodriguez, Lidia Betsabe 19 June 2013 (has links)
No description available.
|
8 |
Mechanisms for modifying the physiochemical and physiomechanical properties of poly (lactic-co-glycoic) acid: the impact on controllled drug deliverySibambo, Sibongile Ruth 29 July 2011 (has links)
MPharm. Faculty of Health Sciences, University of the Witwatersrand, 2007
|
9 |
Fabrication of Controlled Release Devices Using Supercritical Antisolvent MethodLee, Lai Yeng, Smith, Kenneth A., Wang, Chi-Hwa 01 1900 (has links)
In this study, the supercritical antisolvent with enhanced mass transfer method (SASEM) is used to fabricate micro and nanoparticles of biocompatible and biodegradable polymer PLGA (poly DL lactide co glycolic acid). This process may be extended to the encapsulation of drugs in these micro and nanoparticles for controlled release purposes. Conventional supercritical antisolvent (SAS) process involves spraying a solution (organic solvent + dissolved polymer) into supercritical fluid (CO[subscript 2]), which acts as an antisolvent. The high rate of mass transfer between organic solvent and supercritical CO[subscript 2] results in supersaturation of the polymer in the spray droplet and precipitation of the polymer as micro or nanoparticles occurs. In the SASEM method, ultrasonic vibration is used to atomize the solution entering the high pressure with supercritical CO[subscript 2]. At the same time, the ultrasonic vibration generated turbulence in the high pressure vessel, leading to better mass transfer between the organic solvent and the supercritical CO₂. In this study, two organic solvents, acetone and dichloromethane (DCM) were used in the SASEM process. Phase Doppler Particle Analyzer (PDPA) was used to study the ultrasonic atomization of liquid using the ultrasonic probe for the SASEM process. Scanning Electron Microscopy (SEM) was used to study the size and morphology of the polymer particles collected at the end of the process. / Singapore-MIT Alliance (SMA)
|
10 |
The Effect of the Physical Form of Biodegradable Polymer Carriers on the Humoral Immune Response to Co-Delivered AntigenBennewitz, Nancy Lee 02 December 2004 (has links)
The biomaterial component of a tissue engineered device has been shown to enhance the immune response to a co-delivered model shed antigen. The purpose of this research was to investigate in vivo the differential level of the immune response toward different forms of the biomaterial. A model shed antigen, ovalbumin (OVA), was incorporated into polymeric biomaterial carriers made of 50:50 poly(lactic-co-glycolic acid) (PLGA) in the form of microparticles (MP) or scaffolds (SC). These MP and SC biomaterial carrier vehicles with incorporated antigen were then injected or implanted, respectively, into C57BL6 mice to investigate the differential level of the immune response towards OVA controlled release from PLGA MP and PLGA SC. For each polymeric carrier, the resulting time-dependent systemic humoral immune response towards the incorporated OVA, the OVA-specific IgG concentration and isotypes (IgG2a or IgG1, indicating a predominant Th1 or Th2 response, respectively) were determined using ELISA. To assess the differential level of the immune response depending on the form of PLGA, the total amounts of polymer and OVA delivered were kept constant as well as the release rate of OVA. The in vitro protein release kinetics were studied for both PLGA MPs and PLGA scaffolds to examine the release rate of OVA from the polymeric carriers.
The level of the humoral immune response was higher and sustained for OVA released from PLGA SC which were implanted with associated tissue damage, and lower and transient when the same amount of polymer and OVA were delivered from PLGA MP, which were minimally invasively delivered by injection. This immune response was primarily Th2 helper T cell-dependent as exemplified by the predominance of IgG1 isotype, although for the strong adjuvant, Complete Freunds adjuvant (CFA), and PLGA SC carriers the anti-OVA IgG2a isotype levels were also significant, potentially indicating both a Th2 and Th1 response.
The PLGA SC and PLGA MP exhibited similar protein release kinetics, releasing similar amounts of OVA at each time point. Each carrier incubated contained the same ratio of OVA to polymer. In vitro protein release kinetics experiments suggest that the rate of release of OVA from PLGA SC and PLGA MP was similar, and therefore the enhanced immune response induced by PLGA SC is most likely due to danger signals from implantation which primed the system for an enhanced immune response and not from a difference in concentration of OVA released from the carriers.
|
Page generated in 0.0429 seconds